ulab Systems™ Named to the 2021 CB Insights Digital Health 150 List of Most Innovative Startups
MEMPHIS, Tenn., Jan. 25, 2022 /PRNewswire/ -- CB Insights named uLab Systems, creator of the uSmile™ clear aligner system and...
Year: 2022
Univfy and PracticeHwy Announce Partnership to Expand Access to Artificial Intelligence/Machine Learning Platform for Fertility Providers and Patients
SAN FRANCISCO BAY AREA, Calif. and IRVING, Texas, Jan. 25, 2022 /PRNewswire/ -- Univfy, a global leader in using artificial intelligence...
Agfa appoints Scott Evers as Senior Vice President & North American Business Leader
ELMWOOD PARK, N.J., Jan. 25, 2022 /PRNewswire/ -- AGFA Imaging Solutions North America, is pleased to announce that Scott Evers...
Akerna Releases 2021 Cannabis Industry Year-End Review
DENVER, Jan. 25, 2022 /PRNewswire/ -- Akerna (Nasdaq: KERN), a leading enterprise software company and the developer of the most comprehensive...
Lockheed Martin Aeronautics adopts Siemens’ Xcelerator portfolio to support digital engineering transformation
PLANO, Texas, Jan. 25, 2022 /PRNewswire/ -- Lockheed Martin's Aeronautics business has selected Siemens' Xcelerator portfolio of software and services...
Mobile Health Launches Fully Integrated DTx Suite to Further Simplify Health and Wellbeing for Employees
SAN MATEO, Calif., Jan. 25, 2022 /PRNewswire/ -- Mobile Health, the digital health and wellbeing solution that makes it easy for...
Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments
SAN FRANCISCO, Jan. 25, 2022 /PRNewswire/ -- Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, announced...
Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Booster Candidate and Publication of Data on Booster Durability Against Omicron Variant
Phase 2 study of Omicron-specific booster candidate (mRNA-1273.529) will include two cohorts: one including participants who received the two-dose primary...
Psyched Wellness Provides Update on Anti-Inflammatory Study with the National Research Council of Canada
Toronto, Ontario--(Newsfile Corp. - January 26, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
CBD of Denver Announces Access to Audit Results and Upcoming Board Meeting
Denver, Colorado--(Newsfile Corp. - January 26, 2022) - CBD of Denver, Inc. (OTC Pink: CBDD), Cultivator, Distributor of CBD and...
Anesthesia Business Consultants to Attend the ASA® ADVANCE 2022
JACKSON, Mich.--(BUSINESS WIRE)--Anesthesia Business Consultants (ABC), a leading provider in billing and practice management for the anesthesia and pain management...
ESO Identifies Key Hospital Trends to Watch in 2022
Focus will be on staffing challenges, emerging technology, training and education, as well as financial hurdles AUSTIN, Texas--(BUSINESS WIRE)--ESO, the...
Female Clinicians Spend More Time on Patient Care Documentation, Contributing to Lower Pay and Higher Burnout, athenahealth Study Finds
Findings show that female clinicians hold an average of 13 fewer patient encounters per week and spend more time in...
United States e-Prescribing Market Outlook & Forecast Report 2022-2027 – AI to Eradicate Prescription Errors & Develop Indication-Based Prescribing Systems – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "U.S. E-Prescribing Market - Industry Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The report...
Morris Chestnut and Obi Obadike and The Ethical Company Are Set To Change The Health Of The Globe Ethically One Supplement At A Time
LOS ANGELES, Jan. 26, 2022 /PRNewswire/ -- Today, Founders Actor Morris Chestnut and Celebrity & Fitness Nutrition Expert Obi Obadike...
Planet 13 Announces Impending Effectiveness of Form 10 Registration Statement
LAS VEGAS, NV / ACCESSWIRE / January 26, 2022 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),...
IBA Launches Compact Low-Energy Cyclotron, Cyclone® KEY
New accelerator provides increased access to diagnosis solutions and enables in-house production of radiopharmaceuticals Louvain-la-Neuve, Belgium, 26 January 2022 -...
Value Specialty Pharmacy Selects The Inovalon ONE® Platform’s Leading SaaS Capabilities
Innovative Specialty Pharmacy Leader to Implement ScriptMed® Cloud to Improve Clinical Outcomes for Patients BOWIE, Md., Jan. 26, 2022 (GLOBE...
Panbela Initiates a Randomized, Double-Blind, Placebo-Controlled Study (ASPIRE) of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma
MINNEAPOLIS, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for...
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Company Announcement COPENHAGEN, Denmark; January 26, 2022 – Genmab A/S (Nasdaq: GMAB) – In accordance with Article 19 of Regulation...